Cogprints

Pacemaker Prevention Therapy in Drug–refractory Paroxysmal Atrial Fibrillation: Reliability of Diagnostics and Effectiveness of Prevention Pacing Therapy in Vitatron™ Selection® device

Terranova, Paolo and Valli, Paolo and Terranova, Peppino and Dell’Orto, Simonetta and Greco, Enrico Maria (2006) Pacemaker Prevention Therapy in Drug–refractory Paroxysmal Atrial Fibrillation: Reliability of Diagnostics and Effectiveness of Prevention Pacing Therapy in Vitatron™ Selection® device. [Journal (Paginated)]

Full text available as:

[img]HTML
48Kb
[img]
Preview
PDF
427Kb

Abstract

Introduction. Atrial fibrillation (AF), the most common and rising disorder of cardiac rhythm, is quite difficult to control and/or to treat. Non pharmacological therapies for AF may involve the use of dedicated pacing algorithms to detect and prevent atrial arrhythmia that could be a trigger for AF onset. Selection 900E/AF2.0 Vitatron DDDRP pacemaker (1) keeps an atrial arrhythmia diary thus providing detailed onset reports of arrhythmias of interest, (2) provides us data about the number of premature atrial contractions (PACs) and (3) plots heart rate in the 5 minutes preceding the detection of an atrial arrhythmia. Moreover, this device applies four dedicated pacing therapies to reduce the incidence of atrial arrhythmia and AF events. Aim of the Study. To analyze the reliability to record atrial arrhythmias and evaluate effectiveness of its AF preventive pacing therapies. Material and Methods. We enrolled 15 patients (9 males and 6 females, mean age of 71±5 years, NYHA class I–II), with a DDDRP pacemaker implanted for a “bradycardia–tachycardia” syndrome, with advanced atrioventricular conduction disturbances. We compared the number and duration of AF episodes’ stored in the device with a contemporaneous 24h Holter monitoring. After that, we switched on the atrial arrhythmias detecting algorithms, starting from an atrial rate over 180 beats per minute for at least 6 ventricular cycles, and ending with at least 10 ventricular cycles in sinus rhythm. Thereafter, in order to evaluate the possible reduction in PACs number and in number and duration of AF episodes, we tailored all the four pacing preventive algorithms. Patients were followed for 24±8 months (from 20 to 32 months). Results. All 59 atrial arrhythmia episodes occurred in the first part of this trial, were correctly recorded by both systems, with a correlation coefficient (r) of 0.96. During the follow–up, we observed a significant reduction not only in PACs number (from 83±12/day to 2.3±0.8/day) but also in AF episodes (from 46±7/day to 0.12±0.03/day) and AF burden (from 93%±6% to 0.3%±0.06%). An increase in atrial pacing percentages (from 3%±0.5% to 97%±3%) was also contemporaneously observed. Conclusion. In this pacemaker, detection of atrial arrhythmia episodes is highly reliable, thus making available an appropriate monitoring of heart rhythm, mainly suitable in AF asymptomatic patients. Moreover, the significant reduction of atrial arrhythmia episodes indicates that this might represent a suitable therapeutic option for an effective preventive therapy of AF in paced brady–tachy patients.

Item Type:Journal (Paginated)
Keywords:Sick Sinus Syndrome, Atrial Fibrillation, Atrial Pacing, Pacing Algorithms, Non-Pharmacological Therapy
Subjects:JOURNALS > Indian Pacing and Electrophysiology Journal
ID Code:4799
Deposited By:Indian Pacing and Electrophysiology, Journal
Deposited On:01 Apr 2006
Last Modified:11 Mar 2011 08:56

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Levy S, Campbell RW, Camm AJ, Daubert JC, Alessie M, Aliot E, et al. on behalf of the Working Group on Arrhythmias of the European Society of Cardiology. Atrial fibrillation: current knowledge and recommendations for management. Europ Heart J 1998; 19: 1294-1320

2. Fuster V, Ryden L, Asinger RW, Cannom DS, Crijns HJ, Frye RL et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001; 22: 1852-1923

3. Wolff, PA; Abbott, RD; Kannell, WR. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983–988

4. Furberg, CD; Psaty, BM; Manolio, TA. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Card 1994; 74: 236–241

5. Levy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Criojns HJ et al. International consensus on nomenclature and classification of atrial fibrillation. Europace 2003; 5: 119-122

6. Zipes DP. Atrial fibrillation. A tachycardia-induced cardiomyopathy. Circulation 1977; 95: 562-564

7. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins. New Engl J Med 1998; 339: 659-666

8. Alessie MA, Boyden P, Camm AJ, Kleber AG, Lab MJ, Legato MJ et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 769-777

9. Honjo H, Boyett MR, Niwa R, Inada S, Yamamoto M, Mitsui K et al. Pacing–induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine. Circulation 2003; 107: 1937-1943

10. Lombardi F, Colombo A, Basilico B, Ravaglia R, Garbin M, Vergani D et al. Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol 2001; l37: 157-162

11. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie M. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968

12. Sgarbossa, EB; Pinski, SL; Maloney, JD. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Circulation1993; 88: 1045–1053

13. Rosenqvist, M; Brandt, J; Shuller, H. Long–term pacing in sinus node disease: effects of stimulation node on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16–22

14. Santini, M; Alexidou, G; Ansalone, G; et al. Relation of prognosis in sick sinus syndrome to age, conduction defects, and mode of permanent cardiac pacing. Am J Cardiol 1990; 65: 729–735

15. Andersen, HR; Nielsen, JC; Thomsen, PEB; at al. Long–term follow–up of patients from a randomised trial of atrial versus ventricular pacing for sick–sinus syndrome. Lancet 1997; 350: 1210–1216

16. Saksena, S; Prakash, A; Hill, M; et al. Prevention of recurrenty atrial fibrillation with a specifically designed coronary sinus lead. J Am Coll Cardiol 1996; 28: 987–694

17. Daubert, C; Leclerq, C; Le Breton, H; et al. Permanent left atrial pacing with a specifically designed coronary sinus lead. PACE 1997 ; 20: 2755–2764

18. Padeletti, L; Porciani, MC; Michelacci, A; et al. Interatrial septum pacing a new site to pace simultaneously both atria on patients with paroxysmal atrial fibrillation. Third International Symposium on Pacing Leads. Ferrara, Italy, 11–13 September 1997: 229–232

19. Israel, CW; Hugl, B; Unterberg, C; Lawo, T; Kennis, I; Hettrick, D; Hohnloser, SK; AT500 Verification Study Investigators. Pace–termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12(10): 1121–1128

20. Fauchier, L; Briand, F; Soto, FX; Quennelle, F; Levy, J; Darmon, JP; Lellouche, D; Lavergne, T; Poret, P; Pelade, C; Babuty, D. Management of atrial tachyarrhythmias: benefits of pacemaker diagnostics. J Cardiovasc Electrophysiol 2003; 26 (1 Pt 2): 233–238

21. Kale, M; Bennett, DH. Pacemaker prevention therapies for the control of drug–refractory paroxysmal atrial fibrillation. Europace 2003; 5(2): 123–131

22. Lee, MA; Weachter, R; Pollak, S; Kremers, MS; Naik, AM; Silverman, R; Tuzi, J; Wang, W; Johnson, LJ; Euler, DE; ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003; 41 (11): 1926–1932

23. Stephenson; EA; Casavant, D; Tuzi, J; Alexander, ME; Law, I; Serwer, G; Strieper, M; Walsh, EP; Berul, CI; ATTEST Investigators. Effects of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003; 92(7): 871–876

24. Ricci, R; Santini, M; Padeletti, L; Boriani, G; Capucci, A; Botto, G; Gulizia, M; Inama, G; Galati, A; Solimene, F; Pepe, M; Grammatico, A. Atrial tachyarrhythmia reurrence temporal patterns in bradicardia patients implanted with antitachycardia pacemakers. J Cardiovasc Electrophysiol 2004; 15(1): 44–51

25. Carlson MD, Ip J, Messenger J, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the atrial dynamic overdrive pacing trial (ADOPT). J Am Coll Card 2003; 42: 627-33.

26. Lee MA. Weachter R. Pollak S. Kremers MS. Naik AM. Silverman R. Tuzi J. Wang W. Johnson LJ. Euler DE. ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia

and atrial tachyarrhythmias. Journal of the American College of Cardiology.2003; 41(11):1926-32,

27. Mitchell AJ, Sulke N. How do trial pacing algorithms prevent atrial arrhythmias? Europace 2004; 6: 351–362

28. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val–Mejias J, Mackall J, Gold M, for the Atrial Dynamic Overdrive Pacing Trial (ADOPT). A new pacemaker algorithm for the treatment of atrial fibrillation. JACC 2003; 42(4):627–633

29. Sack S, Mouton E, Defaye P, Dagres N, Wolfhard U, Wieneke H, Herrmann J, Oldenburg O, Golles A, Erbel R; AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Asistance. Improved detection and analysis of sensed and paced events in dual chamber pacemakers with extended memory function. A prospective multicenter trial in 626 patients. Herz. 2001 Feb; 26(1): 30–39.

30. Defaye P, Mouton E. A new diagnostic concept in cardiac pacing for the evaluation of the incidence of atrial arrhythmias. Results of the AIDA study. Arch Mal Coeur Vaiss. 1999 Jun; 92(6): 719–726.

31. Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol. 1998 Jan;21(1 Pt 2):250-5.

32. Limousin M, Geroux L, Nitzsche R, Cazeau S, Pioger G, Victor J, Poty H, Puglisi A, Ricci R. Value of automatic processing and reliability of stored data in an implanted pacemaker: initial results in 59 patients. Pacing Clin Electrophysiol. 1997 Dec;20(12 Pt 1):2893-8.

33. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. New Engl J Med 2002; 347: 1825

34. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834

35. G.Nicotra, E.Barducci. Optimising the Diagnostics of Atrial Ffibrillation (AF) in Implantable Devices by Checking Atrial Re fractory Period and Atrial Sensitivity. Europace 2001; 2(A): A41

36. Saad EB, Schweikert RA. Atrial fibrillation: When is rate control enough? Cleve Clin J Med. 2004 Sep;71(9):713-8.

37. Tse HF, Newman D, Ellenbogen KA, Buhr T, Markowitz T, Lau CP; Atrial Fibrillation SYMPTOMS investigators. Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]). Am J Cardiol. 2004 Oct 1;94(7):938-41.

38. Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL; AFFIRM Investigators. The Atrial Fibrillation Followup Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol. 2004 Apr 7;43(7):1201-8.

39. Tse HF, Lau CP. Prevalence and clinical implications of atrial fibrillation episodes detected by pacemaker in patients with sick sinus sindrome. Heart. 2005 Mar;91(3):362-4.

40. Wilkinson DA, Popham P, Morgan D. Pacemaker interference from cardiac monitors revisited. Anaesth Intensive Care. 2004 Dec;32(6):842-3.

Metadata

Repository Staff Only: item control page